advertisement

---

Xu H 9

Showing records 1 to 9 | Display all abstracts from Xu H

104691 Trends in the prevalence of vision impairment among the oldest-old Chinese population from 1998 to 2018
Luo Y
Journal of global health 2022; 12: 11006

---

104388 Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy: A Pilot Study
Xu H; Lee D
Ophthalmology. Glaucoma 2022; 5: 658-662

---

104691 Trends in the prevalence of vision impairment among the oldest-old Chinese population from 1998 to 2018
Zhang Q; Han L
Journal of global health 2022; 12: 11006

---

104388 Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy: A Pilot Study
Cho J
Ophthalmology. Glaucoma 2022; 5: 658-662

---

104691 Trends in the prevalence of vision impairment among the oldest-old Chinese population from 1998 to 2018
Shen Z
Journal of global health 2022; 12: 11006

---

104388 Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy: A Pilot Study
Voss J; McDaniel L
Ophthalmology. Glaucoma 2022; 5: 658-662

---

104691 Trends in the prevalence of vision impairment among the oldest-old Chinese population from 1998 to 2018
Chen Y
Journal of global health 2022; 12: 11006

---

104388 Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy: A Pilot Study
An JA
Ophthalmology. Glaucoma 2022; 5: 658-662

---

104691 Trends in the prevalence of vision impairment among the oldest-old Chinese population from 1998 to 2018
Wang K; Huang Z; De Fries CM; Cao G; Su H; Xu H; Chen Z; Ren Z; Hu Y; Xu B
Journal of global health 2022; 12: 11006

---